NCT06389617

Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block

Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block for Creation of Arteriovenous Fistula in End Stage Renal Disease: A Randomized Controlled Trial

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Hospital Universiti Sains Malaysia · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

To compare the analgesic properties of ultrasound guided supraclavicular block using ropivacaine 0.5% in arteriovenous fistula creation when used in combination with intravenous administered dexamethasone at 4mg and 8 mg as an adjuvant

Conditions

• End Stage Renal Failure

Interventions

Type	Name	Description
DRUG	supraclavicular block with 20mls of Ropivacaine 0.5% and Intravenous administered dexamethasone	Comparing the onset of sensory, motor block, duration of motor block and analgesic duration

Timeline

• Start date: 2024-05-01
• Primary completion: 2024-11-30
• Completion: 2024-12-30
• First posted: 2024-04-29
• Last updated: 2024-04-29